232 related articles for article (PubMed ID: 29108577)
1. Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.
Hu LL; Meng J; Zhang DD; Chen ML; Shu Y; Wang JH
Talanta; 2018 Jan; 177():203-211. PubMed ID: 29108577
[TBL] [Abstract][Full Text] [Related]
2. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
[TBL] [Abstract][Full Text] [Related]
3. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
[TBL] [Abstract][Full Text] [Related]
4. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and doxorubicin high-loaded nanodrug based on biocompatible thioether- and ethane-bridged hollow mesoporous organosilica nanoparticles.
Zhang J; Weng L; Su X; Lu G; Liu W; Tang Y; Zhang Y; Wen J; Teng Z; Wang L
J Colloid Interface Sci; 2018 Mar; 513():214-221. PubMed ID: 29153715
[TBL] [Abstract][Full Text] [Related]
6. Tumor Acidic Microenvironment Targeted Drug Delivery Based on pHLIP-Modified Mesoporous Organosilica Nanoparticles.
Zhang Y; Dang M; Tian Y; Zhu Y; Liu W; Tian W; Su Y; Ni Q; Xu C; Lu N; Tao J; Li Y; Zhao S; Zhao Y; Yang Z; Sun L; Teng Z; Lu G
ACS Appl Mater Interfaces; 2017 Sep; 9(36):30543-30552. PubMed ID: 28809111
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of biodegradable auto-fluorescent organosilica nanoparticles with dendritic mesoporous structures for pH/redox-responsive drug release.
Li X; Chen Y; Zhang X; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110914. PubMed ID: 32409066
[TBL] [Abstract][Full Text] [Related]
8. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable Mesoporous Organosilica Nanosheets for Chemotherapy/Mild Thermotherapy of Cancer: Fast Internalization, High Cellular Uptake, and High Drug Loading.
Chen L; Meng X; Liu M; Lv R; Cai B; Wang Z
ACS Appl Mater Interfaces; 2020 Jul; 12(27):30234-30246. PubMed ID: 32525649
[TBL] [Abstract][Full Text] [Related]
10. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
11. Schiff base interaction tuned mesoporous organosilica nanoplatforms with pH-responsive degradability for efficient anti-cancer drug delivery in vivo.
Liu L; Kong C; Huo M; Liu C; Peng L; Zhao T; Wei Y; Qian F; Yuan J
Chem Commun (Camb); 2018 Aug; 54(66):9190-9193. PubMed ID: 30062359
[TBL] [Abstract][Full Text] [Related]
12. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
[TBL] [Abstract][Full Text] [Related]
15. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery.
Fan J; Zhang Z; Wang Y; Lin S; Yang S
J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777
[TBL] [Abstract][Full Text] [Related]
16. Chitosan based nanogels stepwise response to intracellular delivery kinetics for enhanced delivery of doxorubicin.
Zuo Y; Kong M; Mu Y; Feng C; Chen X
Int J Biol Macromol; 2017 Nov; 104(Pt A):157-164. PubMed ID: 28600203
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
18. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable organosilica magnetic micelles for magnetically targeted MRI and GSH-triggered tumor chemotherapy.
Yang T; Niu D; Chen J; He J; Yang S; Jia X; Hao J; Zhao W; Li Y
Biomater Sci; 2019 Jun; 7(7):2951-2960. PubMed ID: 31099352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]